Exosome Outsourcing Outsourced exosome isolation and MISEV-compliant characterization service (including NTA, Western blot and freeze-drying) lets researchers access specialized capabilities without building in-house infrastructure; ideal for academic labs, biotech startups, and pharmaceutical researchers seeking validated exosome workflows.

PODS Partnerships PODS sustained-release growth factors enable local, prolonged protein delivery in vitro and in vivo; target neuroscience, oncology and regenerative medicine programs, and explore co-development with biomaterials partners to create therapy pipelines.

Global Reach Cambridge base with a US office and collaborations such as the Derby partnership provide routes for cross-border sales, co-development deals, and distribution partnerships in Europe and North America.

Credibility Boost Recognition as UK Life Sciences Innovator 2023 can accelerate talks with potential customers, grant programs and pilot projects, helping to establish credibility in new markets and with prospective collaborators.

Cytogenetics Synergy Karyotype analysis and AGH testing for academic and commercial labs present an additional revenue stream; consider cross-selling to exosome and PODS customers who need cell line validation or genomic integrity checks.